As highly
targeted radiation options become more widely available, many cancer patients
are finding that their treatment involves higher doses delivered over a shorter
period of time. While this can be especially helpful in treating a variety of
cancers while limiting the procedures patients must endure, researchers are
finding that higher dose delivery isn’t always the best path to take. For
low-risk prostate cancer patients, in fact, a new study indicates that higher
dose treatments may not always produce the best results.
